Saturday, December 4, 2021

Carlyle Group Expands COVID Portfolio with CNSI

The Carlyle Group added to its extensive COVID-19 portfolio with its planned buyout of healthcare IT provider CNSI.  

CNSI operates at the unique intersection of technology, healthcare and government services, and we see significant growth opportunities ahead as the company leverages its unique capabilities and continues to develop market-leading solutions.”

The deal is expected to close this month.  Washington, D.C. based Carlyle has long sought companies that tap Uncle Sam's wallet. 

Carlyle's presence in China tipped the PEU off to COVID-19's massive profit opportunity.  The private equity underwriter (PEU) began growing its COVID-19 portfolio in February 2020. 

Prior to India's devastating COVID surge Carlyle invested in a drug manufacturer that produced Ivermectin.   McLean, Virginia based CNSI has a presence in India as well:

Headquartered in the United States with a major technology center in Chennai, India, CNSI employs a world-class team.

India experienced nearly 500,000 COVID deaths to date.  

In August 2020 WSJ reported:

(Carlyle Group co-founder) David Rubenstein has been ruminating about death lately. “Covid has made me realize my own mortality,” says the 71-year-old billionaire co-executive chairman of the Carlyle Group Inc., a private-equity firm he co-founded in Washington in 1987. “You kind of say, ‘How come 170,000 people have died and I haven’t?’” 
U.S. COVID deaths passed 808,000.  Were some of Rubenstein's ruminations on how to profit from widespread disease and death?  Highly likely.

In March 2020 Carlyle Group co-founder David Rubenstein's family office invested in COVID test maker Vault.  Uncle Sam is spending big money on COVID home tests. 

Rubenstein interviewed Dr. Anthony Fauci via Duke University's Global Health Institute in February 2021.

Rubenstein:  Will we have access to home COVID-19 screening tests any time soon?

Fauci:  The U.S. government has contracted with a company that makes a rapid point-of-care, sensitive and specific home test that people will soon be able to obtain at a pharmacy and you can use it to test yourself any time you want.  

There was no declaration of a possible conflict of interest in the interview.  Rubenstein owned Vault offers in home COVID testing:

Vault serves the following states; Idaho, Minnesota, West Virginia, New Mexico and Delaware. 

 

President Biden's home state is Delaware and he recently spent Thanksgiving at the Nantucket estate of David Rubenstein.  It's a small world for policy making billionaires.

The other ways The Carlyle Group can profit from COVID-19 include:

  • infrared screen people in airports for fever (Schneider Electric & HGH), 
  • test for COVID antibodies (Ortho Clinical), 
  • assist with blood plasma collection (MAK Systems), 
  • produce antibody drug conjugate (Piramal Pharma Solutions), 
  • ensure the maximum hospital bill for COVID-19 patients (TrustHCS), 
  • manufacture Ivermectin treatment (SeQuent Scientific) 
  • make federal coronavirus purchasing something other than a Jared Kushner clown show (Unison)

The greed and leverage boys will make big money on COVID.  It's the way our world works.  Politicians Red and Blue love PEU.

Update 6-13-22:  CNSI has a new board stacked with Carlyle executives.  It also has the former Deputy Director for Medicare/Medicaid and chair of MACPAC.  Carlyle has long used former government insiders for profit purposes.